Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Schizophrenia, Psychiatric, Psychiatric, Bipolar Disorder |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2018 |
| Start Date: | March 1, 2018 |
| End Date: | June 30, 2020 |
Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI Accessing Community Care
Schizophrenia and bipolar disorder are associated with high risk for suicide, yet there are
few brief interventions that directly target suicide prevention in this large population. The
goal of this intervention development study is to evaluate the feasibility, acceptability,
and preliminary effectiveness of a brief intervention called SafeTy and Recovery Therapy
(START) that is augmented with content delivered on mobile devices outside of the clinic
setting. The intervention will evaluated in a community urgent care center context as people
initiate outpatient care, and, if effective, could be deployed in a wide network of such
centers.
few brief interventions that directly target suicide prevention in this large population. The
goal of this intervention development study is to evaluate the feasibility, acceptability,
and preliminary effectiveness of a brief intervention called SafeTy and Recovery Therapy
(START) that is augmented with content delivered on mobile devices outside of the clinic
setting. The intervention will evaluated in a community urgent care center context as people
initiate outpatient care, and, if effective, could be deployed in a wide network of such
centers.
This intervention development research project evaluates the feasibility, acceptability, and
preliminary impact of a brief cognitive behavioral intervention, tailored to SMI, that is
delivered during the gap period between urgent care evaluation and follow-up outpatient care.
SafeTy and Recovery Therapy (START) is a 4-session cognitive behavioral intervention
augmented by mobile technology, which delivers automated and personalized reinforcement of
adaptive coping behavior outside of the clinic setting. START builds from collaborative
development alongside a community psychiatric service organization, and our preliminary data
in the SMI population that supports the feasibility, acceptability, and impact of brief,
mobile augmented cognitive behavioral intervention.
In a 3-year developmental study, our deployment focused approach will first refine
intervention procedures, safety and care continuity protocols, and fit with the deployment
setting with a series of collaborative contacts with community providers, project staff,
advisors, and patient advocates. We will next conduct a pilot randomized controlled trial
with 70 patients diagnosed with either bipolar disorder or schizophrenia rapidly referred by
community triage providers to receive START in the walk-in clinic setting. Patients are
enrolled who have SMI diagnoses and current active suicidal ideation and/or a suicide attempt
in the prior 3 months. Participants are randomized to one of two active conditions: START +
Mobile augmentation or START alone. We will evaluate feasibility, acceptability, and
enhancement of rates of outpatient treatment engagement and crisis service use in comparison
to the sample population. We will also examine pragmatic mechanisms, which include outpatient
treatment engagement and coping self-efficacy, on change in suicidal ideation severity and
crisis service use along with the preliminary impact of mobile augmentation.
preliminary impact of a brief cognitive behavioral intervention, tailored to SMI, that is
delivered during the gap period between urgent care evaluation and follow-up outpatient care.
SafeTy and Recovery Therapy (START) is a 4-session cognitive behavioral intervention
augmented by mobile technology, which delivers automated and personalized reinforcement of
adaptive coping behavior outside of the clinic setting. START builds from collaborative
development alongside a community psychiatric service organization, and our preliminary data
in the SMI population that supports the feasibility, acceptability, and impact of brief,
mobile augmented cognitive behavioral intervention.
In a 3-year developmental study, our deployment focused approach will first refine
intervention procedures, safety and care continuity protocols, and fit with the deployment
setting with a series of collaborative contacts with community providers, project staff,
advisors, and patient advocates. We will next conduct a pilot randomized controlled trial
with 70 patients diagnosed with either bipolar disorder or schizophrenia rapidly referred by
community triage providers to receive START in the walk-in clinic setting. Patients are
enrolled who have SMI diagnoses and current active suicidal ideation and/or a suicide attempt
in the prior 3 months. Participants are randomized to one of two active conditions: START +
Mobile augmentation or START alone. We will evaluate feasibility, acceptability, and
enhancement of rates of outpatient treatment engagement and crisis service use in comparison
to the sample population. We will also examine pragmatic mechanisms, which include outpatient
treatment engagement and coping self-efficacy, on change in suicidal ideation severity and
crisis service use along with the preliminary impact of mobile augmentation.
All subjects are recruited from San Diego area "walk-in" behavioral health evaluation
services and must be referred by a triage clinician at such facilities. The study is unable
to accept referrals from other sources. In addition, the following criteria apply:
Inclusion Criteria:
1. Subjects must have present suicidal ideation CSSR-S> 2 ("Active thoughts of killing
oneself") in past 1 month and/or a suicide attempt in the prior 3 months as identified
by the Columbia Suicide Severity Rating Scale
2. Diagnosis of DSM-V bipolar disorder, schizophrenia, or schizoaffective disorder as
identified by the MINI International Neuropsychiatric Interview
3. Plans to remain in San Diego region for at least 6 months,
4. Capable of informed consent.
Exclusion Criteria:
1. Not English speaking
2. Cannot complete the assessment battery;
3. Insufficient visual acuity/manual dexterity for navigating a touch screen;
4. Current intoxication or substance use requiring immediate detoxification or outpatient
plan directed at substance abuse services (versus mental health services which are
separate in San Diego county);
5. Under conservatorship requiring proxy consent.
We found this trial at
1
site
The University of California, San Diego UC San Diego is an academic powerhouse and economic...
Click here to add this to my saved trials
